Investors
In 2004 Aesica was formed through a management buyout of the former BASF site at Cramlington, Northumberland. The deal was funded by LDC, the private equity arm of Lloyds TSB Group, which took a significant minority stake in the business.
- Active Pharmaceutical Ingredients
- Custom Synthesis
- Excellence in Quality
- Manufacturing Capability
- Testimonials
